BRLI : Analysis & Opinions
June 22, 2012The decision of whether to buy Bio-Reference really comes down to an investor's confidence in the growth prospects for the ...
April 24, 2012LabCorp is feeling pressures from large health insurers and the government, but the company remains firmly profitable and ...
March 16, 2012If you're interested in looking beyond blue-chip growth stocks, consider these sector leaders that pack a lot of value in ...
January 26, 2011Novartis takes another step into molecular diagnostics.